MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.54
+0.13 (+9.22%)
Open$1.46
Previous Close$1.41
Day High$1.55
Day Low$1.39
52W High$25.54
52W Low$13.60
Volume—
Avg Volume744.3K
Market Cap57.82M
P/E Ratio47.21
EPS$0.50
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,887.0% upside
Current
$1.54
$1.54
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.21M | 24.43M | 24.83M |
| Net Income | -6,058,807 | -7,358,364 | -5,671,741 |
| Profit Margin | -26.1% | -30.1% | -22.8% |
| EBITDA | -8,420,768 | -8,749,975 | -9,471,019 |
| Free Cash Flow | -5,731,518 | -5,557,893 | -4,395,902 |
| Rev Growth | +13.9% | -4.6% | +12.3% |
| Debt/Equity | 0.38 | 0.41 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |